WallStreetZenWallStreetZen

NASDAQ: OLMA
Olema Pharmaceuticals Inc Stock Ownership - Who owns Olema Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Olema Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Cyrus HarmonDirector2024-03-2820,000$10.97
$219.40kSell
Naseem ZojwallaCHIEF MEDICAL OFFICER2024-03-1813,700$4.87
$66.72kBuy
Cyrus HarmonDirector2024-02-2924,900$12.41
$309.01kSell
Cyrus HarmonDirector2024-02-29100$13.00
$1.30kSell
Cyrus HarmonDirector2024-02-015,000$15.56
$77.80kSell
Cyrus HarmonDirector2024-01-3125,000$12.23
$305.75kSell
Naseem ZojwallaCHIEF MEDICAL OFFICER2024-01-2520,000$7.02
$140.40kBuy
Shane William Charles KovacsCH. OPERATING FINANCIAL OFF.2024-01-1250,000$7.02
$351.00kBuy
Cyrus HarmonDirector2023-12-292,500$14.10
$35.25kSell
Cyrus HarmonDirector2023-12-2922,500$13.30
$299.25kSell

1 of 6

OLMA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OLMA insiders and whales buy or sell their stock.

OLMA Shareholders

What type of owners hold Olema Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Inc16.34%9,135,893$90.90MInstitution
Paradigm Biocapital Advisors LP14.14%7,903,600$78.64MInstitution
Paradigm Biocapital Advisors LP14.14%7,903,600$78.64MInsider
Logos Global Management LP7.84%4,383,875$43.62MInstitution
Cormorant Asset Management LP5.85%3,270,544$32.54MInsider
Blackrock Inc5.84%3,263,907$32.48MInstitution
Vanguard Group Inc4.84%2,705,895$26.92MInstitution
Cormorant Asset Management LP4.39%2,456,800$24.45MInstitution
G. Walmsley Graham4.19%2,343,114$23.31MInsider
Deep Track Capital LP3.45%1,930,894$19.21MInstitution

1 of 3

OLMA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OLMA71.71%28.29%Net BuyingNet Selling
IGMS37.27%54.63%Net BuyingNet Buying
LYEL51.66%46.21%Net Selling
ANAB41.94%58.06%Net SellingNet Selling
GHRS56.89%0.00%
View Top Biotech Stocks

Olema Pharmaceuticals Stock Ownership FAQ

Who owns Olema Pharmaceuticals?

Olema Pharmaceuticals (NASDAQ: OLMA) is owned by 92.27% institutional shareholders, 36.39% Olema Pharmaceuticals insiders, and 0.00% retail investors. Paradigm Biocapital Advisors LP is the largest individual Olema Pharmaceuticals shareholder, owning 7.90M shares representing 14.14% of the company. Paradigm Biocapital Advisors LP's Olema Pharmaceuticals shares are currently valued at $78.64M.

If you're new to stock investing, here's how to buy Olema Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.